AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06088797 — intervention group
Intervention type: OTHER
Intervention: Tasks assessing number sense based on relative positions or lengths
Description: Pointing exercises on a digital line of 50 cm paper tape: the participant points with his finger to a position on the tape, according to the verbal request of the experimenter~Measures the intermanual gap during requests for evaluation of 5 times the wand, subtracting the length of a wand, then dividing this length by 2.
Study NCT06088797 — intervention group
Intervention type: OTHER
Intervention: WISC V Similarity and Span Test
Description: The Wechsler Intelligence Scale for Children - Fifth Edition, Australian Standard (WISC-V) is an individually administered and comprehensive clinical instrument used to assess the general thinking and reasoning skills of children aged six years to 16 years. Test results include a Full-Scale Intelligence Quotient (IQ) score as well as age-equivalent rankings and scores for Verbal Comprehension, Visual Spatial, Fluid Reasoning, Working Memory and Processing Speed composites
Study NCT06088797 — intervention group
Intervention type: OTHER
Intervention: WISC V Arithmetic subtest
Description: The WISC-V is an individually administered, comprehensive clinical instrument for assessing the intelligence of children. The primary and secondary subtests are on a scaled score metric with a mean of 10 and a standard deviation (SD) of 3. These subtest scores range from 1 to19, with scores between 8 and 12 typically considered average.
Study NCT04793581 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Atherectomy
Description: Directional atherectomy of lesions below the knee.
Study NCT06414005 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TPX-115
Description: Ultrasound-guided intratendinous injection of allogeneic fibroblasts (TPX-115)
Study NCT06414005 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (Saline)
Description: Ultrasound-guided intratendinous placebo injection
Study NCT05643443 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gradual increase of force
Description: steady force
Study NCT04830878 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: Systemic and intraoperative intravitreal injection of methotrexate
Study NCT04103502 — intervention group
Intervention type: DEVICE
Intervention: MicroPort Medial Pivot TKA
Description: Subjects will have been implanted with the MicroPort Medial Pivot TKA
Study NCT04103502 — intervention group
Intervention type: DEVICE
Intervention: DePuy Attune PCR TKA
Description: Subjects will have been implanted with the DePuy Attune PCR TKA
Study NCT05865925 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY010616
Description: IV infusion was 90min (±5min), with an interval of 3 weeks between the first administration and the second administration, and once every 2 weeks thereafter
Study NCT06097273 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 0.9% sodium chloride suspension for injection
Study NCT06097273 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Influenza Vaccine
Description: Commercially available formulation (Suspension for injection \[pre-filled syringe\])
Study NCT06097273 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: COVID-19 Vaccine
Description: Commercially available formulation (Suspension for injection)
Study NCT06230952 — intervention group
Intervention type: OTHER
Intervention: BASDAI and BASFI reliability
Description: The study will be carried out on volunteer patients who are diagnosed with axial spondyloarthritis and are followed up in the outpatient clinic of Dokuz Eylül University, Department of Internal Medicine, Rheumatology and Immunology Department, and who meet the inclusion criteria. Patients who volunteer to participate in the study will be contacted by phone and BASDAI and BASFI questionaires will be administered.
Study NCT05963451 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention will be given in our study since, the investigators are recruiting people who will receive already a facet thermal ablation.
Study NCT06264037 — intervention group
Intervention type: OTHER
Intervention: semi structured interview
Description: semistructured interview on patient\&#39;s experience of hospitalization.
Study NCT04934982 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Total Laparoscopic or Robotic Radical Hysterectomy
Description: Stage IA1 with lymphovascular interstitial infiltration and IA2 surgical approach was type B (modified radical hysterectomy plus bilateral pelvic lymph node dissection, i.e., resection of 1\~2 cm of the parametrium and 1\~2 cm of the vagina) with abdominal para-aortic lymph node dissection if necessary (surgical staging according to FIGO 2018 and surgical staging according to Querleu-Morrow staging).
Study NCT04934982 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Total Abdominal Radical Hysterectomy
Description: Stage IA1 with lymphovascular interstitial infiltration and IA2 surgical approach was type B (modified radical hysterectomy plus bilateral pelvic lymph node dissection, i.e., resection of 1\~2 cm of the parametrium and 1\~2 cm of the vagina) with abdominal para-aortic lymph node dissection if necessary (surgical staging according to FIGO 2018 and surgical staging according to Querleu-Morrow staging).
Study NCT04760223 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video intervention
Description: a 100-second video, presenting a personal story of a boy/girl dealing with depression
Study NCT04760223 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Video intervention
Description: a 100-second video, presenting a personal story of a boy/girl dealing with depression
Study NCT05869656 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fluid restriction
Description: Oral fluid restriction of 1000ml per day
Study NCT05869656 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Free fluids
Description: Continue care without any oral fluid restriction
Study NCT06252090 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Short term mentalization-based treatment for adolescents (MBT-A)
Description: The general framework of intervention corresponds to the Mentalization-Based Treatment model for adolescents (MBT-A). In this study, the model was adapted to a brief, time-limited format (12 sessions) aimed at both the adolescent and their family. The model retains the main characteristics of Mentalization-Based Therapy, such as the therapist's basic attitude toward actively promoting patients' mentalization, uncertainty of mental states, focus on the here and now, and the use of affect as a mechanism for change.
Study NCT06187272 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Listening to music
Description: Students listened to background music during a practical examination of 60 bpm.
Study NCT04896684 — intervention group
Intervention type: BIOLOGICAL
Intervention: blood and intestinal biopsy sampling
Description: 24 mL of blood and 10 intestinal biopsies will be sampled
Study NCT06342245 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiofrequency coblation micro-tenotomy
Description: Radiofrequency micro-tenotomy with low-temperature controlled ablation will be performed with the TOPAZ (Smith and Nephew) wand, which has a 1mm tip, and full thickness 1mm RF tendon debridement at 5mm intervals will be performed.
Study NCT05745181 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CAR-T Cell Infusion
Description: Peripheral blood mononuclear cells were isolated, amplified and cultured in vitro, pretreated with FC regimen, and Anti-CD1a CAR-T cells were transfused.
Study NCT05404217 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: LN-OS-22
Description: 2 capsules orally once a day to be taken with a glass of milk after breakfast for 56 days
Study NCT05404217 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: 2 capsules orally once a day to be taken with a glass of milk after breakfast for 56 days
Study NCT05089981 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: N acetyl cysteine
Description: Intravenous use of N acetyl cysteine in prescribed doses
Study NCT05089981 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of N acetyl cysteine
Description: Intravenous Placebo of N Acetyl cysteine in look alike form (Normal saline)
Study NCT05135793 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topoprazan
Description: 1 tablet contains 20 mg vonoprazan
Study NCT05135793 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Takecab
Description: 1 tablet contains 20 mg vonoprazan
Study NCT05588947 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Take Charge session
Description: A 'talk therapy' session designed to harness the person's self-determination, re-establishing purpose, identity, autonomy, and skills to Take Charge of their recovery after stroke
Study NCT05588947 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active Control
Description: Life After Stroke educational video
Study NCT05571423 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Medical Play
Description: Study subject will be engage in the medical play.
Study NCT05571423 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Routine Play
Description: Study subject will be engage in the routine play (coloring exercise).
Study NCT04765553 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NI-0501
Description: emapalumab single i.v infusion (1 mg/kg)
Study NCT04765553 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Saline single i.v infusion
Study NCT04383847 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sumadhur Aarambha
Description: Group intervention for newly married women, their husbands, and mothers-in-law with information mainly about nutrition, but also pre-pregnancy health, reproductive/pregnancy health and gender equality.
Study NCT06105762 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ketogenic Diet
Description: The ketogenic diet intervention, administered as a Modified Atkins Diet, involves a significantly reduced daily carbohydrate intake, typically less than 20 grams of net carbs. This approach primarily relies on higher fat consumption to induce ketosis, a metabolic state characterized by elevated ketone body production, serving as an alternative brain fuel source.
Study NCT06105762 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ketogenic Diet
Description: The ketogenic diet intervention, administered as a Modified Atkins Diet, involves a significantly reduced daily carbohydrate intake, typically less than 20 grams of net carbs. This approach primarily relies on higher fat consumption to induce ketosis, a metabolic state characterized by elevated ketone body production, serving as an alternative brain fuel source.
Study NCT06465992 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Exparel 266 MG Per 20 ML Injection
Description: 20 mL Liposomal bupivacaine (Exparel, 266 mg) will be administered in the popliteal and saphenous block
Study NCT06465992 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine Hcl 0.75% Inj
Description: 10 mL of 0.75% bupivacaine will be administered in popliteal and saphenous block
Study NCT06465992 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: 1 mL of 10 mg Dexamethasone will be administered in the popliteal and saphenous block
Study NCT05390996 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: dental implant placement
Description: dental implant placement by using a different drilling techniques
Study NCT05390996 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: dental implant placement
Description: dental implant placement by using a different drilling techniques
Study NCT05277506 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 18 inch slot MBT orthodontic brackets bonded using smile arc protection bonding strategy
Description: female patients with mild crowding will recieve orthodontic brackets bonding using smile arc protection bonding strategy
Study NCT05277506 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 18 inch slot MBT orthodontic brackets boned using MBT placement guide
Description: female patients with mild crowding will recieve orthodontic brackets bonding using MBT placement guide bonding strategy
Study NCT05238155 — intervention group
Intervention type: DRUG
Intervention: antimetabolite
Description: When OLT recipients are discharged following transplantation, they are typically prescribed a triple immunosuppression maintenance regimen, consisting of a calcineurin inhibitor, an antimetabolite, and a corticosteroid. Over the last several years, there have been changes made to this protocol, and the current protocol now suggests
Study NCT05804461 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Description: Upon refinement from Formative Research (Aim 1), a three-session, individual-level intervention to increase Pre-Exposure Prophylaxis (PrEP) uptake among men who have sex with men (MSM) in Puerto Rico will be implemented. The facilitator will use Motivational Interviewing techniques to guide the sessions. The intervention's design and content will be the same for each study group; the only difference will be the modality of implementation; one group of participants will receive a face-to-face intervention, while another group will receive an online intervention.A total of 170 participants will be randomized in a 1:1 ratio into each of the two intervention modalities (n=85 face-to-face and n=85 online) while a control group will be recruited following a 3:1 ratio of intervention vs. control. In addition to baseline assessment, participants will be asked to complete a post test at the end of the third session (60 days) and a follow-up post-test at the 150-day mark, separately.
Study NCT04166110 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Predetermined treatment duration
Description: Antibiotic treatment duration left to the physician's judgement (following national guidelines, 7 to 14 days)
Study NCT04166110 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Variable treatment duration
Description: Treatment duration vary according to stability criteria reaching time Patients will self-monitor 2 times a day (in the morning and in the evening) using a set of connected devices, to monitor their vital signs before any treatment intake.~After at least 3 days of treatment and stability criteria obtained for the last 24 hours (i.e. 3 vital signs recording), patients will stop the antibiotic treatment.
Study NCT04634370 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Natural Killer Cells infusion
Description: Each patient will receive on dose of intravenous natural killer cell in following levels:~Level 1 : 1x106 cells/kg body weight (patients 1 to 3) Level 2: 5x106 cells/kg body weight (patients 4 to 6) Level 3: 1x107 cells/kg body weight (patients 7 to 24)
Study NCT06018688 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Osimertinib
Description: Osimertinib is a 3rd-generation EGFR-TKI used to treat NSCLC patients with resistance to 1st generation EGFR-TKI due to T790M mutation. It has been approved in clinical applications by the FDA in 2015.
Study NCT06018688 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Aspirin, also known as acetylsalicylic acid (ASA), is a verysafe medication used to treat pain,fever, or inflammation.
Study NCT05507398 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo, metformin and atorvastatin
Description: comparing the anti-tumor effects of metformin and atorvastatin
Study NCT05507398 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo, metformin and atorvastatin
Description: comparing the anti-tumor effects of metformin and atorvastatin
Study NCT05203809 — intervention group
Intervention type: DEVICE
Intervention: TempTraq temperature monitor
Description: All participants will wear both TempTraq temperature monitor and CORE temperature monitor.
Study NCT04713176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWJ1248 with Remdesivir
Description: 1 tablet of DWJ1248 TID(up to 14 days) PO, Remdesivir(up to 5 or 10 days) IV
Study NCT04713176 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo with Remdesivir
Description: 1 tablet of placebo TID(up to 14 days) PO, Remdesivir(up to 5 or 10 days) IV
Study NCT05471804 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Sceletium tortuosum
Description: Zembrin® is a proprietary low-alkaloid extract of Sceletium tortuosum, often consumed by healthy humans in order to decrease anxiety and stress and improve cognitive function under stressful situations
Study NCT05471804 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sceletium tortuosum
Description: Zembrin® is a proprietary low-alkaloid extract of Sceletium tortuosum, often consumed by healthy humans in order to decrease anxiety and stress and improve cognitive function under stressful situations
Study NCT04843384 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reiki
Description: Reiki was performed according to the need of each patient and lasted an average of 20-25 minutes. After the procedure, the patients were left to rest for ten minutes. The researcher was focused in a neutral way on the sessions without the intention of healing. After the session, the patients were allowed to rest for ten minutes.
Study NCT04843384 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham reiki
Description: With the Sham Reiki patients, a nurse without reiki training performed Sham Reiki randomly for approximately 20-25 minutes, following a protocol which did not include the body's energy centers or chakras.
Study NCT05479188 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cerebral oximetry
Description: Cerebral oximetry monitoring with near-infrared spectroscopy.
Study NCT05479188 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Peripheral oximetry
Description: Tissue perfusion monitoring with somatic near-infrared spectroscopy.
Study NCT05479188 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cerebral autoregulation
Description: Cerebral autoregulation monitoring with COx.
Study NCT05479188 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sublingual microscopy
Description: Evaluation of microcirculation with sublingual microscopy.
Study NCT04841070 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ages & Stages Questionnaires®, Third Edition (ASQ3)
Description: Investigators will propose to parents of children hospitalized for the treatment of persistent pulmonary hypertension of the newborn a hetero-evaluation via the validated ASQ questionnaire to analyze neuro-psychomotor development.
Study NCT05097898 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Clinical examination centered on congestion
Description: Clinical examination centered on congestion (including the EVEREST, Ambrosy and ASCEND score) will be performed during day hospitalization or consultation
Study NCT05097898 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cardiac, pulmonary, peritoneal, jugular and renal Doppler ultrasounds and liver elastography
Description: Cardiac, vena cava, pulmonary, peritoneal, jugular and renal Doppler ultrasounds and liver elastography will be performed during day hospitalization or consultation/ peritoneal, jugular and renal Doppler ultrasounds and liver elastography are optional/Cardiac echo is optional for patients included in consultation
Study NCT05097898 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood and urine sample retrieved for biological assessment and biobanking
Description: Blood sample retrieved for biological assessment and biobanking will be performed during day hospitalization or consultation/ Urine analysis is optional for patients included in consultation
Study NCT05097898 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telephone follow-up
Description: Telephone follow-up will be performed 3, 12 and 24
Study NCT05097898 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Kansas City Cardiomyopathy Questionnaire (KCCQ)
Description: Questionnaire centered on patient's quality of life at discharge and 3, 12 and 24 months after discharge
Study NCT05639504 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: IMX-BVN-4 and IMX-SEV-4
Description: Blood collection for mRNA analysis, Procalcitonin and CRP determination, molecular analysis of nasopharyngeal swab collection
Study NCT06446271 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Plasma biomarker levels
Description: This study will investigate existing and novel biomarkers (including blood, urine electrocardiographic and imaging) at various stages of disease in patients with a personal or family history of TTN, MYBPC3, LMNA, FLNC or DSP gene variant, which are known to cause cardiomyopathy.~Cardiomyopathy will be defined per European Society of Cardiology cardiomyopathy guidelines and heart failure stage will be defined per American Heart Associate guidelines.
Study NCT05469412 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iPad®
Description: Use of Technology.
Study NCT05469412 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam
Description: Standard management combined with pharmacological intervention (oral midazolam 0.5 mg/kg) administered at least 30 min before surgery (maximum 20mg).
Study NCT05738447 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HBV mRNA vaccine
Description: With 20ug as the starting point, the dose was increased using a dose escalation scheme. Each subject only received one corresponding dose, and the intramuscular injection was administered again every 7 days, and after 4 doses, the 5th dose was given after 1-month interval.